Increased carriage of macrolide-resistant fecalE. colifollowing mass distribution of azithromycin for trachoma control | Zendy

Jessica C. Seidman | Zendy; Christian Coles | Zendy; Ellen K. Silbergeld | Zendy; Joshua Levens | Zendy; Harran Mkocha | Zendy; Lashaunda B. Johnson | Zendy; Beatriz Muñoz | Zendy; Sheila K. West | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Increased carriage of macrolide-resistant fecalE. colifollowing mass distribution of azithromycin for trachoma control

Author(s) -

Jessica C. Seidman,

Christian Coles,

Ellen K. Silbergeld,

Joshua Levens,

Harran Mkocha,

Lashaunda B. Johnson,

Beatriz Muñoz,

Sheila K. West

Publication year - 2014

Publication title -

international journal of epidemiology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.406

H-Index - 208

eISSN - 1464-3685

pISSN - 0300-5771

DOI - 10.1093/ije/dyu062

Subject(s) - azithromycin , trachoma , medicine , carriage , feces , veterinary medicine , drug resistance , microbiology and biotechnology , antibiotics , biology , pathology

Mass drug treatment with azithromycin (MDA) is part of the WHO-endorsed 'SAFE' strategy for trachoma control in endemic communities. MDA has been associated with reduced trachoma prevalence and short-term reductions in other bacterial infections, but can also lead to increased circulation of macrolide-resistant bacteria.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research